ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 717

Comparison of Responsiveness of Lupus Impact Tracker with Lupus Quality of Life to Selena Responder Index

Hervé Devilliers1, Narender Annapureddy2, Winston Sequeira3, Joel A Block4 and Meenakshi Jolly2, 1Dijon University Hospital, Department of internal medicine and systemic diseases, Dijon, France, 2Rheumatology, Rush University Medical Center, Chicago, IL, 3rush university, chicago, IL, 4Rush University, Chicago, IL

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: SLE and quality of life

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Lupus Erythematosus - Clinical Aspects and Treatment: Treatment and Management Studies

Session Type: Abstract Submissions (ACR)

Background/Purpose: Lupus Impact Tracker (LIT) is a 10-item patient reported outcome tool to measure the impact of Systemic Lupus Erythematosus (SLE) or its treatment on patients’ daily lives. The transformed scores range from 0-100, where higher scores denote greater impact. The tool is responsive to self-reported changes in SLE health status over time. Herein, we compare the responsiveness of the LIT and LupusQoL (34 items) to changes in disease activity as judged by SLE responder index (SRI).

Methods: Adult SLE patients were prospectively recruited from 20 North American Rheumatology clinics for the LIT study- an observational, non-interventional prospective multi center study conducted across the US and Canada. Data (Demographics, LIT, LupusQoL, BILAG, SELENA-SLEDAI) were obtained three months apart. Modified SRI was defined as (1) a decrease in SELENA-SLEDAI (4 points), (2) No new BILAG A and not more than 1 new B and (3) No increase in Physician Global Assessment (PGA). Latter definition was used as our PGA variable was categorical (0/1/2/3). Standardized response mean (SRM) and effect size (ES) for  LIT and LupusQoL domains were calculated among SRI responders and non-responders by taking the average difference divided by the standard deviation of the differences between the paired measurements at baseline and 3 month visit LIT scores. Kruskall Walis test was used to compare the SRM among SRI responders (R) and non responders (NR).

Results: 325 patients participated (90% Female); 53% Whites, 33% Black and 17% Hispanic. Mean (SD) age and SELENA-SLEDAI at baseline were 42.3 (16.2 ) yrs and 4.3 (3.8), respectively. Mean (SD) LIT score at baseline was 39.4 (22.9). SRI data was available for 295 (40 R and 255 NR) at the 3 month timepoint. LIT SRM (ES) was -0.69 (-0.36) and -0.20 (-0.12) among SRI responders and non-responders respectively, (p=0.02).

For LupusQoL, SRM (ES) for Physical health and Pain domains were 0.42 (0.23) and 0.65 (0.44) respectively.

Conclusion: 10 item LIT was modestly responsive to changes in disease activity as assessed by SRI in patients with SLE in this study Two domains (11 items) of LupusQoL showed responsiveness to SRI . Inclusion of the these tools in clinical care and clinical trials may provide further insight into its responsiveness.

 

 

Responders (n=40)

Non-responders (n=255)

p-value

 

Mean variation

SRM

95% CI

ES

95% CI

Mean variation

SRM

95% CI

ES

95% CI

 

LIT

– 7.9

-0.68

[-1.05;-0.28]

-0.36

[-0.54;-0.16]

-2.9

-0.19

[-0.32;-0.06]

-0,12

[-0.2;-0.04]

0.023

LupusQoL domains

 

 

 

 

 

 

 

 

 

 

 

Physical health

+ 5.7

+ 0.42

[0.07;0.74]

+ 0.23

[0.04;0.41]

+ 0.5

+ 0.03

[-0.09;0.15]

+ 0.02

[-0.05;0.09]

0.042

Pain

+ 12.6

+ 0.65

[0.36;0.91]

+ 0.44

[0.19;0.66]

+ 1.6

+ 0.08

[-0.04;0.20]

+ 0.06

[-0.03;0.13]

0.002

Planning

+ 3.5

+ 0.18

[-0.16;0.50]

+ 0.13

[-0.10;0.37]

+ 1.2

+ 0.07

[-0.06;0.19]

+ 0.04

[-0.03;0.12]

NS

Intimate Relationship

– 0.7

– 0.06

[-0.41;0.27]

– 0.05

[-0.32;0.24]

+ 0.4

+0.02

[-0.09;0.08]

+0.01

[-0.16;0.14]

NS

Burden to others

+ 6.0

+ 0.24

[-0.05;0.55]

+ 0.20

[-0.05;0.44]

+ 3.9

+ 0.18

[0.04-0.31]

+ 0.12

[0.04-0.21]

NS

Emotional health

+ 4.5

+ 0.38

[0.07;0.68]

+ 0.17

[0.03;0.32]

+ 0.3

+ 0.01

[-0.11;0.14]

+ 0.01

[-0.09;0.11]

NS

Body image

+ 4.7

+ 0.29

 

+ 0.15

 

+ 2.7

+ 0.13

 

+ 0.09

 

NS

Fatigue

+ 3.5

+ 0.26

[-0.07;0.56]

+ 0.16

[-0.05;0.36]

+ 2.5

+0.13

[0.01;0.25]

+ 0.09

[0.01;0.17]

NS

 


Disclosure:

H. Devilliers,
None;

N. Annapureddy,
None;

W. Sequeira,
None;

J. A. Block,
None;

M. Jolly,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparison-of-responsiveness-of-lupus-impact-tracker-with-lupus-quality-of-life-to-selena-responder-index/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology